Filtered By:
Vaccination: Covid Vaccine

This page shows you your search results in order of date. This is page number 9.

Order by Relevance | Date

Total 1865 results found since Jan 2013.

Adverse effects of COVID-19 vaccination in patients with Transfusion Dependent Thalassemia (TDT): an observational study from a tertiary care centre in Punjab, India
Acta Haematol. 2023 Jun 16. doi: 10.1159/000531448. Online ahead of print.ABSTRACTVaccination against SARS-CoV2 is the most important weapon in the arsenal in the battle against COVID-19. There is concern about an increased risk of adverse effects in patients with transfusion-dependent thalassemia (TDT), which affects vaccine acceptance. A predesigned questionnaire was used to evaluate adverse effects (local/systemic within 90 days after vaccination) in participants >18 years of age with TDT. A total of 100 patients received 129 vaccine doses. The mean age of the patients was 24.3 ± 5.7 years and M: F ratio of 1.6:1. C...
Source: Acta Haematologica - June 18, 2023 Category: Hematology Authors: Shruti Kakkar Evani Jain Anirudh Jain Priyanka Dewan Source Type: research

Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022
CONCLUSION: Our review confirmed previously established safety risks for TTS and GBS and identified a potential safety concern for myocarditis.PMID:37321898 | PMC:PMC10264169 | DOI:10.1016/j.vaccine.2023.06.023
Source: Vaccine - June 15, 2023 Category: Allergy & Immunology Authors: Emily Jane Woo Julianne Gee Paige Marquez James Baggs Winston E Abara Michael M McNeil Rositsa B Dimova John R Su Source Type: research

Self-reported symptoms after COVID-19 vaccination. Distinct sex, age, and geographical outcomes in Lebanese and Italian cohorts
AbstractFollowing the COVID-19 discovery in December 2019, different vaccines were authorized in 2021 in Italy and Lebanon, but side effects and the impact of sex and age remained partly explored. We designed a web-based “Google Form” questionnaire to record self-reported systemic and local side effects up to 7 days after 1st and 2nd dose of the vaccine in two distinct Italian and Lebanese cohorts. Twenty-one questions in Italian and Arabic languages explored the prevalence and severity of 13 symptoms. Results were compared with respect to living country, timing, sex, and age classes. A total of 1,975 Italian subjects...
Source: Internal and Emergency Medicine - June 15, 2023 Category: Emergency Medicine Source Type: research

Upper extremity deep vein thrombosis following BBIBP ‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
This report presents a 23-year-old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex ultrasound of the right upper extremity revealed upper extremity deep vein thrombosis, and treatment started with oral anticoagulation. It is probably the first upper extremity deep vein thrombosis case following inactivated COVID-19 vaccines.
Source: Clinical Case Reports - June 14, 2023 Category: General Medicine Authors: Ali Riazi, Masood Faghih  Dinevari, Samaneh Abbasian, Amirreza Jabbaripour Sarmadian Tags: CASE REPORT Source Type: research

Viruses, Vol. 15, Pages 1370: Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register & ndash;12-Month Follow-Up
Viruses, Vol. 15, Pages 1370: Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up Viruses doi: 10.3390/v15061370 Authors: Mateusz Babicki Joanna Kapusta Karolina Pieniawska-Śmiech Żaneta Kałuzińska-Kołat Damian Kołat Agnieszka Mastalerz-Migas Piotr Jankowski Michał Chudzik Around the world, various vaccines have been developed to prevent the SARS-CoV-2 virus infection and consequently the COVID-19 disease. However, many patients continue to report persistent symptoms after the acute phase. Since gathering sc...
Source: Viruses - June 13, 2023 Category: Virology Authors: Mateusz Babicki Joanna Kapusta Karolina Pieniawska- Śmiech Żaneta Kałuzińska-Kołat Damian Ko łat Agnieszka Mastalerz-Migas Piotr Jankowski Micha ł Chudzik Tags: Article Source Type: research

Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University
CONCLUSION: This study demonstrated that a heterologous second booster dose of BNT162b2 after two doses of CoronaVac induced elevated IgG against the SARS-CoV-2-spike protein and caused minor adverse reactions in healthcare workers of the Faculty of Medicine, Naresuan University. This study was registered as Thailand Clinical Trials No. TCTR20221112001.PMID:37301707 | PMC:PMC10239901 | DOI:10.1016/j.vaccine.2023.06.017
Source: Vaccine - June 10, 2023 Category: Allergy & Immunology Authors: Supawadee Makanut Apirath Wangteeraprasert Wittawat Jitpewngam Jatuporn Ngoenkam Sutatip Pongcharoen Source Type: research

COVID-19 vaccination and menstrual cycle characteristics: A prospective cohort study
In conclusion, COVID-19 vaccination was associated with a ∼1 day temporary increase in menstrual cycle length, but was not appreciably associated with other menstrual cycle characteristics.PMID:37301706 | PMC:PMC10239900 | DOI:10.1016/j.vaccine.2023.06.012
Source: Vaccine - June 10, 2023 Category: Allergy & Immunology Authors: Amelia K Wesselink Sharonda M Lovett Janice Weinberg Ruth J Geller Tanran R Wang Annette K Regan Mary D Willis Rebecca B Perkins Jennifer J Yland Martha R Koenig Kenneth J Rothman Elizabeth E Hatch Lauren A Wise Source Type: research

Locating Medical Information during an Infodemic: Information Seeking Behavior and Strategies of Health-Care Workers in Germany
CONCLUSION: Non-physician HCWs more often consulted public information sources. Employers/institutions should ensure the supply of professional, targeted COVID-19 information for different HCW groups.PMID:37297742 | DOI:10.3390/healthcare11111602
Source: Pain Physician - June 10, 2023 Category: Anesthesiology Authors: Christopher Holzmann-Littig David Stadler Maria Popp Peter Kranke Falk Fichtner Christoph Schmaderer Lutz Renders Matthias Christoph Braunisch Tarek Assali Louise Platen Marjo Wijnen-Meijer Julia L ühnen Anke Steckelberg Lisa Pfadenhauer Bernhard Haller Source Type: research

Patterns of adverse drug reactions in Jordan: a retrospective analysis of the national pharmacovigilance data registry (2015-2021)
CONCLUSIONS: This study provides contemporary insights into the post-marketing surveillance of drugs in Jordan. The findings are foundational for future studies exploring drug-ADRs causality relationships. Efforts that promote pharmacovigilance concepts should be sustained and enhanced at the national level.PMID:37293991 | DOI:10.1080/14740338.2023.2223957
Source: Expert Opinion on Drug Safety - June 9, 2023 Category: Drugs & Pharmacology Authors: Nizar M Mhaidat Osama Y Alshogran Shoroq M Altawalbeh Jaber M Jaber Hayaa A Banat Dana S Ahmad Worood Alabsi Source Type: research

Analyzing the effect of the COVID-19 vaccine on Parkinson ’s disease symptoms
ConclusionThere was strong evidence of worsening of PD symptoms post COVID-19 vaccination, however it was mostly mild and limited to a couple of days. The worsening had statistically significant moderate positive correlation with vaccine hesitancy and post-vaccine general side effects. A possible causative mechanism of PD symptom worsening using existing scientific knowledge would be stress and anxiety associated with vaccine hesitancy and the extent of post-vaccine general side effects (fever, chills, pain), likely via simulating a mild systemic infection/inflammation the latter already established causes of PD symptom worsening.
Source: Frontiers in Immunology - June 5, 2023 Category: Allergy & Immunology Source Type: research

COVID-19 Can Cause New Cholesterol Problems. What to Know
Not long after the start of the global coronavirus pandemic, it was apparent that many people infected with SARS-CoV-2 were developing persistent and, in some cases, debilitating health problems. Now known widely as post-Covid syndrome or Long COVID, the most common symptoms of this condition are fatigue, attention problems, headaches, muscle or joint pain, and weakness. But those are just the start. Medical researchers have also linked SARS-CoV-2 to lingering complications in multiple organs and systems, and some recent work has found that new-onset cholesterol problems may be an under-recognized but common complication o...
Source: TIME: Health - May 30, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate heart health Source Type: news